Rocket Lab USA Inc. (RKLB)
Official siteINDUSTRIALS • AEROSPACE & DEFENSE • NASDAQ
Market Cap: $41.41B
Last updated: Nov 17, 2026 at 4:44 PM ET
Rocket Lab USA Inc. (RKLB) Statistics
Rocket Lab USA (RKLB) has a market cap of $41.41B and an enterprise value of $36.96B. Its share count is up 23.37% from a year earlier. Revenue grew 59.03% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 10.73% below the market cap, as cash exceeds debt.
| Market Cap | $41.41B |
|---|---|
| Enterprise Value | $36.96B |
| Latest price (Nov 17, 2026) | $55.05 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 40.7x and 6.2x. Its year-end P/S ranged from 8.3x to 61.7x from 2022 to 2025.
| P/S Ratio | 40.7x |
|---|---|
| Forward P/S | 42.3x |
| P/B Ratio | 6.2x |
| P/TBV Ratio | 6.9x |
Price Statistics
The stock is up 20.88% over 52 weeks and trades 11.37% below its 50-day average.
| Beta (1Y) | 3.66 |
|---|---|
| 52-Week Change | +20.88% |
| 1-Month Change | +7.18% |
| 3-Month Change | -27.41% |
| 6-Month Change | -56.76% |
| 5-Year Change | +289.54% |
| Total Return (1Y) | +20.88% |
| Total Return (3Y CAGR) | +135.54% |
| Total Return (5Y CAGR) | +28.91% |
| Return vs SPY (1Y) | +17.12% |
| Max Drawdown (1Y) | -69.39% |
| Max Drawdown (3Y) | -69.39% |
| Sharpe Ratio (1Y) | 0.27 |
| Correlation with SPY (1Y) | 0.54 |
| 50-Day Average | $62.11 |
| 200-Day Average | $78.07 |
| 52-Week Range | $37.57 to $151.00 |
| RSI (14 Days) | 45.2 |
| Average Volume (20 Days) | 18.77M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 8.55x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.55x |
|---|---|
| Quick Ratio | 8.10x |
| Debt / Equity | 0.00x |
| Interest Coverage | -6.94x |
Returns and Efficiency
Return on invested capital is -4.12% over the last 12 months, against a 5-year average of -18.15%.
| Return on Equity (ROE) | -3.91% |
|---|---|
| Return on Assets (ROA) | -3.45% |
| Return on Invested Capital (ROIC) | -4.12% |
| ROE (5Y Average) | -26.23% |
| ROA (5Y Average) | -13.94% |
| ROIC (5Y Average) | -18.15% |
| Asset Turnover | 0.20x |
| Inventory Turnover | 2.05x |
| Receivables Turnover | 7.63x |
| Cash Conversion Cycle | 174 days |
Scores
RKLB has an Altman Z-Score of 28.73, in the safe zone above 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 28.73 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 5 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $881.90M over the last 12 months.
| Revenue | $881.90M |
|---|---|
| Revenue Growth (YoY) | +59.03% |
| Gross Profit | $319.37M |
| Operating Income | -$243.71M |
| Pretax Income | -$208.56M |
| Net Income | -$226.88M |
| EBITDA | -$167.31M |
| Reported EPS (TTM) | -$0.27 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 88.28% of the $6.57B in total assets.
| Cash and Equivalents | $4.45B |
|---|---|
| Total Debt | $3.00M |
| Net Cash | $4.44B |
| Net Cash Per Share | $6.81 |
| Working Capital | $4.64B |
| Shareholder Equity | $5.80B |
| Book Value Per Share | $8.90 |
| Tangible Book Value | $5.19B |
| Tangible Book Per Share | $7.96 |
| Total Assets | $6.57B |
| Total Liabilities | $766.14M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $133.84M of capital spending, operating cash flow left -$325.62M of free cash flow.
| Operating Cash Flow | -$191.78M |
|---|---|
| Capital Expenditures | $133.84M |
| Free Cash Flow | -$325.62M |
| FCF Per Share | -$0.54 |
| Depreciation and Amortization | $73.15M |
| Share Repurchases | $237.65M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -27.64%, against a 5-year average of -76.47%.
| Gross Margin | 36.21% |
|---|---|
| Operating Margin | -27.64% |
| Pretax Margin | -23.65% |
| Net Margin | -25.73% |
| EBITDA Margin | -18.97% |
| FCF Margin | -36.92% |
| Gross Margin (5Y Average) | 17.61% |
| Operating Margin (5Y Average) | -76.47% |
| Net Margin (5Y Average) | -80.82% |
Growth
Revenue grew 41.82% a year over 3 years.
| Revenue Growth (3Y CAGR) | +41.82% |
|---|---|
| Revenue Growth (5Y CAGR) | +76.47% |
| Book Value Per Share Growth (2Y CAGR) | +62.51% |
| Tangible Book Per Share Growth (2Y CAGR) | +62.60% |
Dividends and Yields
RKLB does not pay a dividend. Its free cash flow yield is -0.91%.
| FCF Yield | -0.91% |
|---|---|
| Buyback Yield | -10.89% |
| Shareholder Yield | -10.89% |
Peer Position
Against 11 similar companies, RKLB has the highest P/S and the 11th highest ROIC.
P/S RatioPeer median 4.4x
ROICPeer median 14.78%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +19.54%
| P/S Ratio | 40.7x vs 4.4x median |
|---|---|
| ROIC | -4.12% vs 14.78% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +59.03% vs +19.54% median |
Analyst Forecast
Consensus estimates put revenue growth at 49.35% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +49.35% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Overvalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About RKLB
What is RKLB's market cap?
Rocket Lab USA has a market cap of $41.41B. Its enterprise value, which adds debt and subtracts cash, is $36.96B.
How many shares of RKLB are outstanding?
Rocket Lab USA has 652.26M shares outstanding. The count is up 23.37% from a year earlier.
Does RKLB pay a dividend?
No. Rocket Lab USA does not pay a dividend.
How much debt does RKLB have?
Rocket Lab USA has $3.00M of total debt and $4.45B of cash and equivalents, a net cash position of $4.44B.
RKLB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts